Drug Profile
Pentamidine/chlorpromazine
Alternative Names: Chlorpromazine/pentamidine; CRx-026Latest Information Update: 23 Sep 2010
Price :
$50
*
At a glance
- Originator CombinatoRx
- Developer Zalicus
- Class Antiemetics; Antineoplastics; Antiprotozoals; Antipsychotics; Benzamidines; Phenothiazines
- Mechanism of Action Apoptosis stimulants; KIF11 protein inhibitors; Mitosis inhibitors; Phosphoric monoester hydrolase inhibitors; Protein-tyrosine-phosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 25 May 2007 CombinatoRx completes two phase I/II trials in late-stage or metastatic Solid tumours in the US
- 21 Jul 2005 Pentamidine/chlorpromazine has been licensed to HenKan in Taiwan, China and South Korea
- 20 Jul 2005 This programme is still in active development